LAV Fund
Overview
LAV Fund is a global biomedical venture capital firm with offices in Shanghai, Hong Kong, and Palo Alto. Originating in 2008 as a corporate venture subsidiary of Eli Lilly, it became an independent entity in 2011. The firm specializes in investing in biopharmaceuticals, human therapeutics, medical devices, and diagnostics, focusing on companies developing breakthrough products to treat diseases and improve human health. The firm's investment strategy emphasizes long-term partnerships with exceptional entrepreneurs, providing smart capital to build sustainable companies. LAV Fund is highly selective, supporting entrepreneurs with a unique combination of ambition, experience, leadership, and integrity. The firm adheres to the principle of 'first, do no harm,' offering significant value by assisting in strategic decisions, executive recruitment, industry contacts, and business development opportunities. LAV Fund's portfolio includes investments in companies such as PAQ Therapeutics, which secured $39 million in a Series B funding round on May 5, 2025. The firm's assets under management are approximately $4.5 billion, reflecting its strong position in the venture capital landscape. LAV Fund's team comprises over 50 professionals experienced in science, medicine, investment, and operations, embracing a culture of integrity, teamwork, diligence, and scientific rigor.
Investment Focus
- Focus on innovative healthcare and biotechnology companies developing breakthrough products to treat diseases and improve human health.
Portfolio Companies
Reach LAV Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about LAV Fund
What sectors does LAV Fund invest in?
LAV Fund invests in Medical Devices, Diagnostics, Biopharmaceuticals and Human Therapeutics, and is based in Shanghai, China. LAV Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does LAV Fund invest at?
LAV Fund backs companies at Early Stage, Series A, Series B, Growth, Late Stage and Pre-IPO.
Which regions does LAV Fund invest in?
LAV Fund invests across United States, Hong Kong and China.
What companies has LAV Fund invested in?
LAV Fund's portfolio includes PAQ Therapeutics.
Last updated · Source: ConnectSafely investor database
